1. 363 An ongoing Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456. (September 2015) Authors: Edelman, M.; Matei, D.; Harb, W.; Clark, R.; Sachdev, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma. (September 2015) Authors: Tolcher, A.; Harb, W.; Sachdev, J.; Papadopoulos, K.; Bordoni, R.; Chai, F.; Larmar, M.; Savage, R.; Abbadessa, G.; Saleh, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP14.08: Diagnostic performance of transvaginal sonography for the assessment of myometrial invasion in cases of endometrial cancer. (1st October 2013) Authors: Harb, W.; Oboleviciute, L.; Kruminis, V.; Vaitkiene, D.; Cizauskas, A.; Gaurilcikas, A. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 42:Number 1(2013:Jul.) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗